Suchergebnisse - "Xiong, Wenjun"

PubPharm (176)

1

Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy

enthalten in: Cell chemical biology | 2024

von Yu, H. | Liu, J. | Bu, X. | +23

CommentIn: Nat Rev Drug Discov. 2023 Nov;22(11):873. - PMID 37798466

2

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Li, H. | Sun, Y. | Yao, Y. | +14

3

Construction of Tetrahymena strains with highly active arsenic methyltransferase genes for arsenic detoxification in aquatic environments

enthalten in: Ecotoxicology and environmental safety | 2024

von Xiong, W. | Wei, W. | He, M. | +4

4

Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction : a single-center retrospective study

enthalten in: Surgical endoscopy | 2024

von Li, J. | Xiong, W. | Ou, H. | +7

5

NUCLEAR FACTOR ERYTHROID 2-LIKE 2 (NRF2) FOR USE IN TREATMENT OF AGE-RELATED MACULAR DEGENERATION

enthalten in: Europäisches Patentamt | 2024

von CEPKO CONSTANCE L | XIONG WENJUN

6

Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction: a single-center retrospective study

enthalten in: Surgical endoscopy and other interventional techniques | 2024

von Li, J. | Xiong, W. | Ou, H. | +7

7

Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer

enthalten in: The Journal of clinical investigation | 2024

von Sun, Z. | Zhang, T. | Ahmad, M. | +16

8

Entorhinohippocampal cholecystokinin modulates spatial learning by facilitating neuroplasticity of hippocampal CA3-CA1 synapses

enthalten in: Cell reports | 2023

von Su, J. | Huang, F. | Tian, Y. | +11

9

NUCLEAR FACTOR ERYTHROID 2-LIKE 2 (NRF2) FOR USE IN TREATMENT OF AGE-RELATED MACULAR DEGENERATION

enthalten in: Europäisches Patentamt | 2023

von CEPKO CONSTANCE L | XIONG WENJUN

10

NUCLEAR FACTOR ERYTHROID 2-LIKE 2 (NRF2) FOR USE IN TREATMENT OF AGE-RELATED MACULAR DEGENERATION

enthalten in: Europäisches Patentamt | 2023

von CEPKO CONSTANCE L | XIONG WENJUN

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]